| Phase 4 |
| NCT07246564 |
Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese… |
Myasthenia Gravis |
Recruiting |
2026-09-11 |
| Phase 3 |
| NCT05077904 |
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… |
Stereotypical Prolonged Seizures |
Recruiting |
2026-09-29 |
| NCT07463521 |
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… |
Ocular Myasthenia Gravis |
Recruiting |
2026-09-25 |
| NCT07465289 |
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult… |
Ocular Myasthenia Gravis |
Recruiting |
2026-09-24 |
| NCT06617325 |
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants… |
Systemic Lupus Erythematosus |
Recruiting |
2026-09-04 |
| NCT07219420 |
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With… |
Palmoplantar Pustulosis |
Recruiting |
2026-08-27 |
| NCT04715646 |
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents… |
Epilepsy |
Recruiting |
2026-07-27 |
| NCT06668181 |
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in… |
Enthesitis-related Arthritis |
Recruiting |
2026-07-17 |
| NCT05063162 |
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… |
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) |
Active, Not Recruiting |
2026-09-25 |
| NCT05076617 |
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants… |
Stereotypical Prolonged Seizures |
Enrolling by Invitation |
2026-09-25 |
| NCT06921850 |
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and… |
Hidradenitis Suppurativa |
Active, Not Recruiting |
2026-09-25 |
| NCT04976322 |
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study… |
Systemic Lupus Erythematosus |
Enrolling by Invitation |
2026-09-18 |
| NCT06425549 |
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in… |
Moderate to Severe Plaque Psoriasis |
Active, Not Recruiting |
2026-09-18 |
| NCT06315322 |
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study… |
Childhood Absence Epilepsy |
Active, Not Recruiting |
2026-08-27 |
| NCT06540144 |
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric… |
Generalized Myasthenia Gravis |
Enrolling by Invitation |
2026-08-14 |
| NCT06435312 |
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric… |
Generalized Myasthenia Gravis |
Enrolling by Invitation |
2026-07-31 |
| NCT06506916 |
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study… |
Moderate to Severe Plaque Psoriasis |
Active, Not Recruiting |
2026-07-17 |
| Phase 2/3 |
| NCT06055959 |
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized… |
Generalized Myasthenia Gravis |
Recruiting |
2026-07-31 |
| NCT06149559 |
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe… |
Generalized Myasthenia Gravis |
Active, Not Recruiting |
2026-09-25 |
| Phase 2 |
| NCT07725939 |
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… |
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis |
Recruiting |
2026-09-25 |
| NCT07720375 |
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… |
Non-cystic Fibrosis Bronchiectasis |
Recruiting |
2026-09-11 |
| NCT07277660 |
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and… |
Atopic Dermatitis |
Active, Not Recruiting |
2026-09-25 |
| Phase 1 |
| NCT06888193 |
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers… |
Moderate to Severe Plaque Psoriasis |
Recruiting |
2026-09-18 |
| NCT06961747 |
A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women |
Healthy Participants |
Recruiting |
2026-08-27 |
| NCT07290036 |
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly… |
Psoriatic Arthritis |
Recruiting |
2026-07-06 |